DroneShield partners with Lockheed Martin Australias STELaRLab for collaboration

Nov 09, 2023

DroneShield Ltd (ASX: DRO) has announced a collaboration with Lockheed Martin Australia's STELaRLab. In this partnership, DroneShield's DroneCannon Mk2, a wide area non-kinetic effector, has been incorporated into Lockheed Martin Australia's Agile Shield program. Agile Shield, a program created under the Next Generation Technologies Fund and DST Group's Counter Improvised Threats Grand Challenge, is specifically designed to counter uncrewed aerial systems (C-UAS).

The initiative focuses on developing innovative solutions to mitigate the threat posed by unmanned aerial vehicles and enhance security measures against such airborne threats. Kevin McDonald, STELaRLab's Integrated Systems Lead, emphasized the incorporation of diverse Australian sensors and effectors in an open mission framework. This strategy guarantees a swift, adaptable, and efficient response to aerial threats. STELaRLab played a key role in developing the open mission systems architecture and acted as the main systems integrator, facilitating the successful integration of DroneShield's technology into Agile Shield's framework.

 

 

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com